Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1994;90:156-162

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brodie, B. R.
Right arrow Articles by Woodlief, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brodie, B. R.
Right arrow Articles by Woodlief, L. H.

Circulation, Vol 90, 156-162, Copyright © 1994 by American Heart Association


ARTICLES

Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction. Final results from the Primary Angioplasty Registry

BR Brodie, CL Grines, R Ivanhoe, W Knopf, G Taylor, J O'Keefe, RA Weintraub, LG Berdan, JE Tcheng and LH Woodlief
Department of Medicine, Moses H. Cone Memorial Hospital, Greensboro, NC.

BACKGROUND: After direct angioplasty in the setting of acute myocardial infarction, patients were followed clinically and angiographically for 6 months at six experienced centers to evaluate outcomes. METHODS AND RESULTS: Of 258 patients with 6-month follow-up after surviving initial hospitalization, 5 (2%) died, 8 (3%) had nonfatal infarctions, 56 (22%) had chest pain, of whom 25 (10%) required hospitalization, and 42 (16%) patients needed repeat angioplasty. Of 203 eligible patients, 154 (76%) had angiographic follow-up. The infarct-related artery remained patent (defined as TIMI 2 or 3 flow) in 87%, while 13% developed reocclusion (TIMI 0 or 1 flow) by 6 months after discharge. Patients with reocclusion were more likely to have adverse events, including 35% with clinically evident reinfarction and 59% requiring repeat angioplasty. The median ejection fraction improvement from acute to follow-up study was 6%, with no improvement in patients with a reoccluded infarct- related artery and an 8% improvement in patients with a patent infarct- related artery. CONCLUSIONS: The positive clinical outcomes recorded immediately after direct angioplasty persisted through 6 months of follow-up. Although the incidence of clinical end points was equivalent to or lower than thrombolytic therapy trials, restenosis is a substantial problem. These findings provide evidence beyond the initial hospitalization that direct angioplasty is a reasonable choice for the treatment of acute myocardial infarction.


This article has been cited by other articles:


Home page
HeartHome page
G Parodi, G Memisha, R Valenti, M Trapani, A Migliorini, G M Santoro, and D Antoniucci
Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience
Heart, December 1, 2005; 91(12): 1541 - 1544.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G Montalescot, H R Andersen, D Antoniucci, A Betriu, M J de Boer, L Grip, F J Neumann, and M T Rothman
Summary of recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction
Heart, June 1, 2004; 90(6): 676 - 677.
[Full Text] [PDF]


Home page
HeartHome page
G Montalescot, H R Andersen, D Antoniucci, A Betriu, M J de Boer, L Grip, F J Neumann, and M T Rothman
Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction
Heart, June 1, 2004; 90(6): e37 - e37.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. L. Grines, D. R. Westerhausen Jr, L. L. Grines, J. T. Hanlon, T. L. Logemann, M. Niemela, W. D. Weaver, M. Graham, J. Boura, W. W. O'Neill, et al.
A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: The air primary angioplasty in myocardial infarction study
J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1713 - 1719.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Constantinides, T S N Lo, M Been, and M F Shiu
Early experience with a helical coronary thrombectomy device in patients with acute coronary thrombosis.
Heart, May 1, 2002; 87(5): 455 - 460.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. C. Smith Jr, J. T. Dove, A. K. Jacobs, J. Ward Kennedy, D. Kereiakes, M. J. Kern, R. E. Kuntz, J. J. Popma, H. V. Schaff, D. O. Williams, et al.
ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions
J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2239 - 2239.
[Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Yamasaki, K. Miyoshi, N. Oda, M. Watanabe, H. Miyake, J. Chan, X. Wang, L. Sun, C. Tang, G. McMahon, et al.
Weekly Dosing With the Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor SU9518 Significantly Inhibits Arterial Stenosis
Circ. Res., March 30, 2001; 88(6): 630 - 636.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. R. Le May, M. Labinaz, R. F. Davies, J.-F. Marquis, L. A. Laramee, E. R. O'Brien, W. L. Williams, R. S. Beanlands, G. Nichol, and L. A. Higginson
Stenting versus thrombolysis in acute myocardial infarction trial (STAT)
J. Am. Coll. Cardiol., March 15, 2001; 37(4): 985 - 991.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. Maillard, M. Hamon, K. Khalife, P. G. Steg, F. Beygui, J.-L. Guermonprez, C. M. Spaulding, J.-M. Boulenc, J. Lipiecki, A. Lafont, et al.
A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction
J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1729 - 1736.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
M. Yano, S. Kojima, T. Sugi, Y. Matsumoto, M. Kuramochi, and Y. Yoshitomi
Long-Term Follow-up of Primary Stenting with Coil Stent in Acute Myocardial Infarction
Angiology, February 1, 2000; 51(2): 107 - 114.
[Abstract] [PDF]


Home page
NEJMHome page
C. L. Grines, D. A. Cox, G. W. Stone, E. Garcia, L. A. Mattos, A. Giambartolomei, B. R. Brodie, O. Madonna, M. Eijgelshoven, A. J. Lansky, et al.
Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction
N. Engl. J. Med., December 23, 1999; 341(26): 1949 - 1956.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Van Belle, K. Abolmaali, C. Bauters, E. P. McFadden, J.-M. Lablanche, and M. E. Bertrand
Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients
J. Am. Coll. Cardiol., August 1, 1999; 34(2): 476 - 485.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. R. Thiemann, J. Coresh, W. J. Oetgen, and N. R. Powe
The Association between Hospital Volume and Survival after Acute Myocardial Infarction in Elderly Patients
N. Engl. J. Med., May 27, 1999; 340(21): 1640 - 1648.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Bauters, M. Delomez, E. Van Belle, E. McFadden, J.-M. Lablanche, and M. E. Bertrand
Angiographically Documented Late Reocclusion After Successful Coronary Angioplasty of an Infarct-Related Lesion Is a Powerful Predictor of Long-Term Mortality
Circulation, May 4, 1999; 99(17): 2243 - 2250.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. R. Azar, R. G. McKay, P. D. Thompson, J. A. Hirst, J. F. Mitchell, D. B. Fram, D. D. Waters, and F. J. Kiernan
Abciximab in primary coronary angioplasty for acute myocardial infarction improves short- and medium-term outcomes
J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1996 - 2002.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. J. Brener, L. A. Barr, J. E. B. Burchenal, S. Katz, B. S. George, A. A. Jones, E. D. Cohen, P. C. Gainey, H. J. White, H. B. Cheek, et al.
Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial Infarction
Circulation, August 25, 1998; 98(8): 734 - 741.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
A H Gershlick and R S More
Recent advances: Treatment of myocardial infarction
BMJ, January 24, 1998; 316(7127): 280 - 284.
[Full Text]


Home page
CirculationHome page
C. Bauters, J.-M. Lablanche, E. Van Belle, R. Niculescu, T. Meurice, E. P. Mc Fadden, and M. E. Bertrand
Effects of Coronary Stenting on Restenosis and Occlusion After Angioplasty of the Culprit Vessel in Patients With Recent Myocardial Infarction
Circulation, November 4, 1997; 96(9): 2854 - 2858.
[Abstract] [Full Text]


Home page
CirculationHome page
M. Hamon, C. Bauters, C. Amant, E. P. McFadden, N. Helbecque, J.-M. Lablanche, M. E. Bertrand, and P. Amouyel
Relation Between the Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene and Late Luminal Narrowing After Coronary Angioplasty
Circulation, August 1, 1995; 92(3): 296 - 299.
[Abstract] [Full Text]


Home page
CirculationHome page
C. Bauters, P. Khanoyan, E. P. Mc Fadden, P. Quandalle, J.-M. Lablanche, and M. E. Bertrand
Restenosis After Delayed Coronary Angioplasty of the Culprit Vessel in Patients With a Recent Myocardial Infarction Treated by Thrombolysis
Circulation, March 1, 1995; 91(5): 1410 - 1418.
[Abstract] [Full Text]


Home page
Journal Watch DermatologyHome page
Angioplasty for MI: Six-Month Outcomes
Journal Watch Dermatology, September 1, 1994; 1994(901): 15 - 15.
[Full Text]


Home page
JWatch GeneralHome page
ANGIOPLASTY FOR MI: SIX-MONTH OUTCOMES
Journal Watch (General), July 26, 1994; 1994(726): 3 - 3.
[Full Text]